Search research articles
Contact Us
Filters
Showing results (311-320 of 408) with videos related to
Page
of 41
Sort By:
Pediatric Blood & Cancer
|
February 27, 2018
Recurrence of Ewing sarcoma: Is detection by imaging follow-up protocol associated with survival advantage?
Melina Heinemann, Andreas Ranft, Thorsten Langer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 19, 2026
<sup>90</sup>Y-FAPI-46 Radiopharmaceutical Therapy in Sarcoma and Other Solid Tumors: An Updated Cohort Analysis
Helena Lanzafame, Ilektra A Mavroeidi, Kim M Pabst, et al.
Ebiomedicine
|
November 7, 2018
Dual-center, dual-platform microRNA profiling identifies potential plasma biomarkers of adult temporal lobe epilepsy
Rana Raoof, Sebastian Bauer, Hany El Naggar, et al.
Scientific Reports
|
May 27, 2021
Wada test results contribute to the prediction of change in verbal learning and verbal memory function after temporal lobe epilepsy surgery
Nadine Conradi, Friederike Rosenberg, Susanne Knake, et al.
JAMA Oncology
|
March 24, 2017
Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial
Heikki Joensuu, Eva Wardelmann, Harri Sihto, et al.
The Lancet. Oncology
|
September 23, 2011
Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes
Patrick Schöffski, Isabelle Laure Ray-Coquard, Angela Cioffi, et al.
The Oncologist
|
March 31, 2026
MyCODE: A prospective evaluation of Lay-language Molecular Tumor Board Protocols in Precision Oncology
Ina Pretzell, Anke Fleischhauer, Ilektra Mavroeidi, et al.
Cancer
|
March 31, 2021
Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas
Inga-Marie Schaefer, Meijun Z Lundberg, Elizabeth G Demicco, et al.
Cancer Discovery
|
September 25, 2020
Resistance to Avapritinib in PDGFRA-Driven GIST Is Caused by Secondary Mutations in the PDGFRA Kinase Domain
Susanne Grunewald, Lillian R Klug, Thomas Mühlenberg, et al.
The Oncologist
|
December 10, 2020
Optimal Avapritinib Treatment Strategies for Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors
Cissimol P Joseph, Sarah N Abaricia, Michelle A Angelis, et al.
Page
of 41
Search research articles
Search
Showing results (311-320 of 408) with videos related to
Sort By:
Page
of 41
Pediatric Blood & Cancer
|
February 27, 2018
Recurrence of Ewing sarcoma: Is detection by imaging follow-up protocol associated with survival advantage?
Melina Heinemann, Andreas Ranft, Thorsten Langer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 19, 2026
<sup>90</sup>Y-FAPI-46 Radiopharmaceutical Therapy in Sarcoma and Other Solid Tumors: An Updated Cohort Analysis
Helena Lanzafame, Ilektra A Mavroeidi, Kim M Pabst, et al.
Ebiomedicine
|
November 7, 2018
Dual-center, dual-platform microRNA profiling identifies potential plasma biomarkers of adult temporal lobe epilepsy
Rana Raoof, Sebastian Bauer, Hany El Naggar, et al.
Scientific Reports
|
May 27, 2021
Wada test results contribute to the prediction of change in verbal learning and verbal memory function after temporal lobe epilepsy surgery
Nadine Conradi, Friederike Rosenberg, Susanne Knake, et al.
JAMA Oncology
|
March 24, 2017
Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial
Heikki Joensuu, Eva Wardelmann, Harri Sihto, et al.
The Lancet. Oncology
|
September 23, 2011
Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes
Patrick Schöffski, Isabelle Laure Ray-Coquard, Angela Cioffi, et al.
The Oncologist
|
March 31, 2026
MyCODE: A prospective evaluation of Lay-language Molecular Tumor Board Protocols in Precision Oncology
Ina Pretzell, Anke Fleischhauer, Ilektra Mavroeidi, et al.
Cancer
|
March 31, 2021
Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas
Inga-Marie Schaefer, Meijun Z Lundberg, Elizabeth G Demicco, et al.
Cancer Discovery
|
September 25, 2020
Resistance to Avapritinib in PDGFRA-Driven GIST Is Caused by Secondary Mutations in the PDGFRA Kinase Domain
Susanne Grunewald, Lillian R Klug, Thomas Mühlenberg, et al.
The Oncologist
|
December 10, 2020
Optimal Avapritinib Treatment Strategies for Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors
Cissimol P Joseph, Sarah N Abaricia, Michelle A Angelis, et al.
Page
of 41